ICAM-1 and VCAM-1 are considered the key players in SphK1/FAK-mediated carcinogenesis, metastasis and increased cell motility, and their higher serum levels may serve as prognostic markers for tumor progression and metastasis in patients suffering from colorectal cancer [79]. Here, SPHK1 is linked to neoplasm.